Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clinical Profile of Multiple Myeloma in Asia - an Asian Myeloma Network (AMN) Study

Blood (2012) 120 (21): 5035.

https://doi.org/10.1182/blood.V120.21.5035.5035

Published: 2012

Journal Articles

Harvesting of Peripheral Blood Stem Cells Using Plerixafor (MOZOBIL) and Granulocyte-Colony Stimulating Factor in Patients Who Had Never Undergone Stem Cell Collection.

Gerrard Teoh, MBBS, MMed, (Internal, Medicine), Keith Goh, MBBS, FRCS, (Neurosurgery)

Blood (2009) 114 (22): 4236.

https://doi.org/10.1182/blood.V114.22.4236.4236

Published: 2009

Journal Articles

First Asia-Pacific Co-Operative Multicenter Multiple Myeloma Clinical Trial: Preliminary Results of the “dtZ”/“DAZZLE” Study.

Gerrard Teoh, MBBS, MMed, (Internal, Medicine), Kihyun Kim, Alok Srivastava, MD, Vasant Pai, Sung-Soo Yoon, MD, Cheolwon Suh, MD, Yeo-Kyeoung Kim

Blood (2009) 114 (22): 4940.

https://doi.org/10.1182/blood.V114.22.4940.4940

Published: 2009

Journal Articles

Identification of Key Factors That Are Associated with the Clinical Anti-Tumor Effect of Zoledronic Acid in Multiple Myeloma

Gerrard Teoh, MBBS, MMed (Internal Medicine), Liang Piu Koh

Blood (2008) 112 (11): 5204.

https://doi.org/10.1182/blood.V112.11.5204.5204

Published: 2008

Journal Articles

Combination of Bortezomib, Dexamethasone, Thalidomide and Zoledronic Acid (VdtZ) Results in a High Rate of Complete Response in High-Risk Non-Hodgkin Lymphoma

Gerrard Teoh, MBBS, MMed (Internal Medicine), Ai Leen Ang, MBBS, MMed, (Internal Medicine)

Blood (2008) 112 (11): 5008.

https://doi.org/10.1182/blood.V112.11.5008.5008

Published: 2008

Journal Articles

Protein Mapping and Characterization of Post-Translational Modifications of Ku86 Protein Variants in Multiple Myeloma Cell Lines.

Geraline Cow, BSc, Charles Gullo, PhD, Feng Ge, MSc, Gerrard Teoh, MD

Blood (2006) 108 (11): 3510.

https://doi.org/10.1182/blood.V108.11.3510.3510

Published: 2006

Journal Articles

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2006) 108 (11): 5097.

https://doi.org/10.1182/blood.V108.11.5097.5097

Published: 2006

Journal Articles

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2006) 108 (11): 5100.

https://doi.org/10.1182/blood.V108.11.5100.5100

Published: 2006

Journal Articles

The Biochemical Characterization of Three Forms of Ku86 Protein in Multiple Myeloma Cell Lines.

Charles A. Gullo, PhD, Feng Ge, MSc, Geraline Cow, Dip, Gerrard Teoh, MD

Blood (2005) 106 (11): 3416.

https://doi.org/10.1182/blood.V106.11.3416.3416

Published: 2005

Journal Articles

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2005) 106 (11): 5127.

https://doi.org/10.1182/blood.V106.11.5127.5127

Published: 2005

Journal Articles

Decoupling of Normal CD40 / Interleukin-4 Immunoglobulin Heavy Chain Switch Signal Leads to Genomic Instability in RPMI 8226 and SGH-MM5 Multiple Myeloma Cell Lines.

William Hwang, MD, Charles Gullo, PhD, Gerrard Teoh, MD

Blood (2004) 104 (11): 1424.

https://doi.org/10.1182/blood.V104.11.1424.1424

Published: 2004

Journal Articles

CD40 Ligand Stimulation of Multiple Myeloma Cells Results in Upregulation of Surface Expressed Heat Shock Proteins and Increased Antigenicity.

Charles A. Gullo, William Hwang, Melvin Au, Edward A. Greenfield, Kenneth C. Anderson, Gerrard Teoh

Blood (2004) 104 (11): 3351.

https://doi.org/10.1182/blood.V104.11.3351.3351

Published: 2004

Journal Articles

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Gerrard Teoh, MD, William Hwang, MD, Liang Piu Koh, MD, Mickey Koh, MD, Daryl Tan, MD, Charles Gullo, PhD

Blood (2004) 104 (11): 4915.

https://doi.org/10.1182/blood.V104.11.4915.4915

Published: 2004

Journal Articles

Detection of Kaposi’s Sarcoma Herpesvirus DNA Sequences in Multiple Myeloma Bone Marrow Stromal Cells

Dharminder Chauhan, Ajit Bharti, Noopur Raje, Eric Gustafson, Geraldine S. Pinkus, Jack L. Pinkus, Gerrard Teoh, Teru Hideshima, Steve P. Treon, Joyce D. Fingeroth, Kenneth C. Anderson

Blood (1999) 93 (5): 1482–1486.

https://doi.org/10.1182/blood.V93.5.1482

Published: 1999

Journal Articles

Bone Marrow and Peripheral Blood Dendritic Cells From Patients With Multiple Myeloma Are Phenotypically and Functionally Normal Despite the Detection of Kaposi’s Sarcoma Herpesvirus Gene Sequences

Noopur Raje, Jianlin Gong, Dharminder Chauhan, Gerrard Teoh, David Avigan, Zekui Wu, Dongshu Chen, Steven P. Treon, Iain J. Webb, Donald W. Kufe, Kenneth C. Anderson

Blood (1999) 93 (5): 1487–1495.

https://doi.org/10.1182/blood.V93.5.1487

Published: 1999

Journal Articles

Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by Dexamethasone

Steven P. Treon, Joseph A. Mollick, Mitsuyoshi Urashima, Gerrard Teoh, Dharminder Chauhan, Atsushi Ogata, Noopur Raje, Joseph H.M. Hilgers, Lee Nadler, Andrew R. Belch, Linda M. Pilarski, Kenneth C. Anderson

Blood (1999) 93 (4): 1287–1298.

https://doi.org/10.1182/blood.V93.4.1287

Published: 1999

Journal Articles

Adenovirus Vector-Based Purging of Multiple Myeloma Cells

Gerrard Teoh, Ling Chen, Mitsuyoshi Urashima, Yu-Tzu Tai, Leo A. Celi, Dongshu Chen, Dharminder Chauhan, Atsushi Ogata, Robert W. Finberg, Iain J. Webb, Donald W. Kufe, Kenneth C. Anderson

Blood (1998) 92 (12): 4591–4601.

https://doi.org/10.1182/blood.V92.12.4591

Published: 1998

Journal Articles

Anti-Estrogens Induce Apoptosis of Multiple Myeloma Cells

Steven P. Treon, Gerrard Teoh, Mitsuyoshi Urashima, Atsushi Ogata, Dharminder Chauhan, Iain J. Webb, Kenneth C. Anderson

Blood (1998) 92 (5): 1749–1757.

https://doi.org/10.1182/blood.V92.5.1749

Published: 1998

Journal Articles

MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor–Dependent Acute Myeloblastic Leukemia Cells

Mitsuyoshi Urashima, Gerrard Teoh, Dharminder Chauhan, Atsushi Ogata, Shuya Shirahama, Chiharu Kaihara, Masaharu Matsuzaki, Hiroshi Matsushima, Masaharu Akiyama, Youki Yuza, Kihei Maekawa, Kenneth C. Anderson

Blood (1998) 92 (3): 959–967.

https://doi.org/10.1182/blood.V92.3.959

Published: 1998

Journal Articles

p16 INK4A Promotes Differentiation and Inhibits Apoptosis of JKB Acute Lymphoblastic Leukemia Cells

Mitsuyoshi Urashima, James A. DeCaprio, Dharminder Chauhan, Gerrard Teoh, Atsushi Ogata, Steven P. Treon, Yasutaka Hoshi, Kenneth C. Anderson

Blood (1997) 90 (10): 4106–4115.

https://doi.org/10.1182/blood.V90.10.4106

Published: 1997

NARROW

Clinical Profile of Multiple Myeloma in Asia - an Asian Myeloma Network (AMN) Study

Harvesting of Peripheral Blood Stem Cells Using Plerixafor (MOZOBIL) and Granulocyte-Colony Stimulating Factor in Patients Who Had Never Undergone Stem Cell Collection.

First Asia-Pacific Co-Operative Multicenter Multiple Myeloma Clinical Trial: Preliminary Results of the “dtZ”/“DAZZLE” Study.

Identification of Key Factors That Are Associated with the Clinical Anti-Tumor Effect of Zoledronic Acid in Multiple Myeloma

Combination of Bortezomib, Dexamethasone, Thalidomide and Zoledronic Acid (VdtZ) Results in a High Rate of Complete Response in High-Risk Non-Hodgkin Lymphoma

Protein Mapping and Characterization of Post-Translational Modifications of Ku86 Protein Variants in Multiple Myeloma Cell Lines.

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

The Biochemical Characterization of Three Forms of Ku86 Protein in Multiple Myeloma Cell Lines.

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Decoupling of Normal CD40 / Interleukin-4 Immunoglobulin Heavy Chain Switch Signal Leads to Genomic Instability in RPMI 8226 and SGH-MM5 Multiple Myeloma Cell Lines.

CD40 Ligand Stimulation of Multiple Myeloma Cells Results in Upregulation of Surface Expressed Heat Shock Proteins and Increased Antigenicity.

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Detection of Kaposi’s Sarcoma Herpesvirus DNA Sequences in Multiple Myeloma Bone Marrow Stromal Cells

Bone Marrow and Peripheral Blood Dendritic Cells From Patients With Multiple Myeloma Are Phenotypically and Functionally Normal Despite the Detection of Kaposi’s Sarcoma Herpesvirus Gene Sequences

Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by Dexamethasone

Adenovirus Vector-Based Purging of Multiple Myeloma Cells

Anti-Estrogens Induce Apoptosis of Multiple Myeloma Cells

MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor–Dependent Acute Myeloblastic Leukemia Cells

p16 INK4A Promotes Differentiation and Inhibits Apoptosis of JKB Acute Lymphoblastic Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only